Biovie Inc.
BIVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580149
In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $2.88M in total; no superinvestor holds it.
Other share classesBIVIW
13F holders, Q2 2026
Institutional positions in Biovie Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q1 2026
- Shares held
- 1.49M
- +454.7K (+44.1%) vs. Q1 2026
- Total value
- $2.88M
- +$1.44M (+99.8%) vs. Q1 2026
- New holders
- 5
- 8 more added
- Sold out
- 3
- 11 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $2.88M |
| Q1 2026 | 33 | $1.44M |
| Q4 2025 | 35 | $1.34M |
| Q3 2025 | 32 | $2.28M |
| Q2 2025 | 38 | $1.03M |
| Q1 2025 | 37 | $968.2K |
| Q4 2024 | 43 | $1.52M |
| Q3 2024 | 27 | $195.3K |
| Q2 2024 | 50 | $1.79M |
| Q1 2024 | 51 | $3.57M |
| Q4 2023 | 54 | $2.42M |
| Q3 2023 | 57 | $5.95M |
| Q2 2023 | 53 | $8.29M |
| Q1 2023 | 48 | $13.0M |
| Q4 2022 | 39 | $9.50M |
| Q3 2022 | 18 | $1.20M |
| Q2 2022 | 16 | $1.60M |
| Q1 2022 | 14 | $7.14M |
| Q4 2021 | 15 | $7.50M |
| Q3 2021 | 14 | $9.96M |
| Q2 2021 | 12 | $4.85M |
| Q1 2021 | 13 | $4.62M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Biovie Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 605,471 | $1.17M | 0.00% | +530,250+704.9% | Added |
| Diametric Capital, LP | 256,636 | $497.9K | 0.05% | −113,364−30.6% | Reduced |
| Renaissance Technologies LLC | 127,918 | $248.2K | 0.00% | +60,000+88.3% | Added |
| Citadel Advisors LLC | 95,952 | $186.1K | 0.00% | +50,660+111.9% | Added |
| Vanguard Capital Management LLC | 70,906 | $137.6K | 0.00% | −13,161−15.7% | Reduced |
| Geode Capital Management, LLC | 70,752 | $137.3K | 0.00% | −13,451−16.0% | Reduced |
| Philadelphia Trust Co | 50,010 | $97.0K | 0.01% | −25,000−33.3% | Reduced |
| Vanguard Fiduciary Trust Co | 37,557 | $72.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 35,860 | $69.6K | 0.00% | +13,069+57.3% | Added |
| Prelude Capital Management, LLC | 32,583 | $63.2K | 0.00% | −59,480−64.6% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 27,632 | $54.0K | 0.00% | +27,632 | New |
| Northern Trust Corp | 21,820 | $42.3K | 0.00% | +7,631+53.8% | Added |
| Persistent Asset Partners Ltd | 14,996 | $29.1K | 0.01% | +14,996 | New |
| XTX Topco Ltd | 14,228 | $27.6K | 0.00% | −6,998−33.0% | Reduced |
| CAPROCK Group, Inc. | 11,300 | $21.9K | 0.00% | +11,300 | New |
| Allworth Financial LP | 5,600 | $10.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,175 | $4.22K | 0.00% | +2,169+36,150.0% | Added |
| Tower Research Capital LLC (TRC) | 2,064 | $4.00K | 0.00% | −5,476−72.6% | Reduced |
| The PNC Financial Services Group, Inc. | 1,000 | $1.94K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 867 | $1.68K | 0.00% | +636+275.3% | Added |
| Caitong International Asset Management Co., Ltd | 14 | $27 | 0.00% | +11+366.7% | Added |
| Tradewinds Capital Management, LLC | 10 | $20 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10 | $19 | 0.00% | −17−63.0% | Reduced |
| GWM Advisors LLC | 10 | $19 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8 | $15 | 0.00% | −48−85.7% | Reduced |
| Financial Perspectives, Inc | 6 | $12 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5 | $10 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 4 | $8 | 0.00% | +4 | New |
| Harbour Investments, Inc. | 3 | $6 | 0.00% | 00.0% | Unchanged |
| Gill Capital Partners, LLC | 2 | $4 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1 | $2 | 0.00% | −1−50.0% | Reduced |
| Albion Financial Group | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $2 | 0.00% | +1 | New |
| Royal Bank of Canada | 200 | $0 | 0.00% | −5−2.4% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −23,482−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,164−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |